Advances in Nanooncology
Author Information
Author(s): KK Jain
Primary Institution: Jain PharmaBiotech, Basel, Switzerland
Hypothesis
Nanobiotechnology can significantly improve cancer diagnosis and treatment.
Conclusion
Nanobiotechnology has the potential to enhance cancer diagnostics and therapeutics, leading to more personalized treatment approaches.
Supporting Evidence
- Nanoparticles can improve the delivery of cancer drugs, making them more effective.
- Gold nanoparticles can be used for cancer detection with high sensitivity.
- Nanotechnology can help personalize cancer treatments based on individual patient profiles.
Takeaway
Scientists are using tiny particles to help find and treat cancer better, making it easier to target the disease without hurting healthy cells.
Methodology
The review discusses various applications of nanobiotechnology in cancer diagnostics and therapeutics, including the use of nanoparticles for drug delivery and imaging.
Potential Biases
Potential conflicts of interest due to the author's affiliations and funding sources are not disclosed.
Limitations
The review does not provide specific data on clinical outcomes or the long-term effects of nanobiotechnology in cancer treatment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website